FindOwnerSearch
Brands and Their Owners
| Brand | Owner (click to sort) | Address | Description |
|---|---|---|---|
| ABIDE | H. Lundbeck A/S | Ottiliavej 9 Valby 2500 Denmark | Medical and pharmaceutical research services; pharmaceutical research and development; research and development in pharmacology for the purpose of treating diseases involving lipid signaling pathways; research and development in pharmacology for the purpose of treating diseases involving the signaling pathways of the central nervous system; medical research for use in treating central nervous system disorders; pharmaceutical research for treating acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain; medical research for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; laboratory research services relating to pharmaceuticals; pharmaceutical research in the field of enzymes that employ hyper-nucleophilic active-site residues for catalysis, namely, serine, threonine and cysteine hydrolases, proteases, and acyl transferases; pharmaceutical research in the fields of immunology, namely, rheumatology, oncology, namely, immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology, namely, fertility, infectiology, namely, virology, ophthalmology, hepatology, neurology, geriatrics, laboratory medicine, clinical diagnostics, genetics and phenomics, pathology and forensics, proteomics, veterinary medicine and diagnostics, and pharmaceutical research tool development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research using enzymes that employ hyper-nucleophilic active-site residues for catalysis, namely, serine, threonine and cysteine hydrolases, proteases, and acyl transferases for use in drug development; pharmaceutical research, namely, research relating to enzymes that employ hyper-nucleophilic active-site residues for catalysis, namely, serine, threonine and cysteine hydrolases, proteases, and acyl transferases for improving pharmacological properties; pharmaceutical research, namely, research relating to enzymes that employ hyper-nucleophilic active-site residues for catalysis, namely, serine, threonine and cysteine hydrolases, proteases, and acyl transferases for use in connection with a wide variety of therapeutic areas; |
| ABIDE | LUNDBECK LA JOLLA RESEARCH CENTER, INC. | 6 PARKWAY NORTH, SUITE 400 DEERFIELD IL 60015 | Medical and pharmaceutical research services; pharmaceutical research and development; research and development in pharmacology for the purpose of treating diseases involving lipid signaling pathways; research and development in pharmacology for the purpose of treating diseases involving the signaling pathways of the central nervous system; medical research for use in treating central nervous system disorders; pharmaceutical research for treating acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain; medical research for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; laboratory research services relating to pharmaceuticals; pharmaceutical research in the field of enzymes that employ hyper-nucleophilic active-site residues for catalysis, namely, serine, threonine and cysteine hydrolases, proteases, and acyl transferases; pharmaceutical research in the fields of immunology, namely, rheumatology, oncology, namely, immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology, namely, fertility, infectiology, namely, virology, ophthalmology, hepatology, neurology, geriatrics, laboratory medicine, clinical diagnostics, genetics and phenomics, pathology and forensics, proteomics, veterinary medicine and diagnostics, and pharmaceutical research tool development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research using enzymes that employ hyper-nucleophilic active-site residues for catalysis, namely, serine, threonine and cysteine hydrolases, proteases, and acyl transferases for use in drug development; pharmaceutical research, namely, research relating to enzymes that employ hyper-nucleophilic active-site residues for catalysis, namely, serine, threonine and cysteine hydrolases, proteases, and acyl transferases for improving pharmacological properties; pharmaceutical research, namely, research relating to enzymes that employ hyper-nucleophilic active-site residues for catalysis, namely, serine, threonine and cysteine hydrolases, proteases, and acyl transferases for use in connection with a wide variety of therapeutic areas; |
| ABIDE | Abide Therapeutics, Inc. | 10835 Road to the Cure Suite 250 San Diego CA 92121 | Medical and pharmaceutical research services; pharmaceutical research and development; research and development in pharmacology for the purpose of treating diseases involving lipid signaling pathways; research and development in pharmacology for the purpose of treating diseases involving the signaling pathways of the central nervous system; medical research for use in treating central nervous system disorders; pharmaceutical research for treating acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain; medical research for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; laboratory research services relating to pharmaceuticals; pharmaceutical research in the field of enzymes that employ hyper-nucleophilic active-site residues for catalysis, namely, serine, threonine and cysteine hydrolases, proteases, and acyl transferases; pharmaceutical research in the fields of immunology, namely, rheumatology, oncology, namely, immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology, namely, fertility, infectiology, namely, virology, ophthalmology, hepatology, neurology, geriatrics, laboratory medicine, clinical diagnostics, genetics and phenomics, pathology and forensics, proteomics, veterinary medicine and diagnostics, and pharmaceutical research tool development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research using enzymes that employ hyper-nucleophilic active-site residues for catalysis, namely, serine, threonine and cysteine hydrolases, proteases, and acyl transferases for use in drug development; pharmaceutical research, namely, research relating to enzymes that employ hyper-nucleophilic active-site residues for catalysis, namely, serine, threonine and cysteine hydrolases, proteases, and acyl transferases for improving pharmacological properties; pharmaceutical research, namely, research relating to enzymes that employ hyper-nucleophilic active-site residues for catalysis, namely, serine, threonine and cysteine hydrolases, proteases, and acyl transferases for use in connection with a wide variety of therapeutic areas; |
| LONGEVITYX | Longevityx, Inc. | 2780 S. Jones Blvd. #200-3215 Las Vegas NV 89146 | Medical and pharmaceutical research services; pharmaceutical research and development; Pharmaceutical preparations; pharmaceutical preparations for the treatment or prevention of age-related disorders; Drug discovery services; Drug development services; Contract research and development drug discovery services; Downloadable software for the facilitation of communication, namely, allowing patients and healthcare professionals to access and share information in the medical, pharmaceutical and health fields; downloadable software in the nature of a mobile application for facilitation of communication, namely, allowing patients and healthcare professionals to access and share information in the medical, pharmaceutical and health fields; Medical apparatus for treating age-related conditions; Software as a service (SAAS) services featuring software for analyzing, discovering and reporting pharmaceutical research and development; Software as a service (SAAS) services featuring artificial intelligence software for mapping of mutations causing phenotype; Providing a database featuring information relating to drug discovery for age-related disorders; Computer services related to database development and management services for data related to genetic data or age-related disorders; Genetic testing of laboratory animals for research purposes; Scientific research in the field of genetics and genetic engineering; Scientific research in the field of genetics; Laboratory research in the field of gene expression; Medical laboratory services; Mice breeding services; Laboratory services in the field of managing laboratory animals for research purposes; Educational services, namely, conducting classes, seminars, conferences, and workshops in the field of age-related diseases; Providing on-line journals, namely, blogs in the medical, pharmaceutical and health fields; Providing a website featuring information in the medical and health fields; Providing a website featuring information in the field of the diagnostic, prophylactic and therapeutic properties of pharmaceuticals directed to the treatment of age-related disorders; |
| MARENDA | Marenda Pharmaceuticals | 16192 Coastal Highway Lewes DE 19958 | Medical and pharmaceutical research services; medical and pharmaceutical research and development; providing scientific research information in the fields of medicine and pharmaceuticals; |
| ONCOLYZE | ONCOLYZE, INC. | c/o Daniel DeWolf 666 3rd Avenue New York NY 10017 | medical and pharmaceutical research services; pharmaceutical research and development; |
| PARTICIPATION IN A CLINICAL TRIAL IS THE FIRST STEP IN FIGHTING CANCER, NOT THE LAST | SCRI Holdings | One Park Plaza Nashville TN 37203 | medical and pharmaceutical research services in the field of healthcare; |
| PUTTING THE IMMUNE SYSTEM TO WORK | Medarex, Inc. | 707 State Road Princeton NJ 08540 | medical and pharmaceutical research services; |
Where the owner name is not linked, that owner no longer owns the brand |